The past three weeks in the stock market have been highly volatile. The S & P 500 saw its worst session in eight months on June 5, just days after the index reached record highs. The CNBC Investing ...
Abstract: The integration of three-dimensional (3-D) printing into point-of-care (PoC) settings enables the fabrication of patient-specific medical devices such as anatomical models, surgical guides, ...
WAUWATOSA, Wis. & NEWARK, Del.--(BUSINESS WIRE)--N-Zyme Biomedical, a clinical-stage biotechnology company developing a novel class of therapeutics targeting pepsin in reflux disease, today announced ...
Company advancing a first-in-class approach to targeting pepsin, with the potential to redefine the standard of care; recently granted patents from the U.S. Patent and Trademark Office and Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results